Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,791 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Costs and staffing resource requirements for adaptive clinical trials: quantitative and qualitative results from the Costing Adaptive Trials project.
Wilson N, Biggs K, Bowden S, Brown J, Dimairo M, Flight L, Hall J, Hockaday A, Jaki T, Lowe R, Murphy C, Pallmann P, Pilling MA, Snowdon C, Sydes MR, Villar SS, Weir CJ, Welburn J, Yap C, Maier R, Hancock H, Wason JMS. Wilson N, et al. Among authors: murphy c. BMC Med. 2021 Oct 26;19(1):251. doi: 10.1186/s12916-021-02124-z. BMC Med. 2021. PMID: 34696781 Free PMC article.
Development, effectiveness and cost-effectiveness of a new out-patient Breathlessness Support Service: study protocol of a phase III fast-track randomised controlled trial.
Bausewein C, Jolley C, Reilly C, Lobo P, Kelly J, Bellas H, Madan P, Panell C, Brink E, De Biase C, Gao W, Murphy C, McCrone P, Moxham J, Higginson IJ. Bausewein C, et al. Among authors: murphy c. BMC Pulm Med. 2012 Sep 19;12:58. doi: 10.1186/1471-2466-12-58. BMC Pulm Med. 2012. PMID: 22992240 Free PMC article. Clinical Trial.
Improving outcomes in adults with epilepsy and intellectual disability (EpAID) using a nurse-led intervention: study protocol for a cluster randomised controlled trial.
Ring H, Gilbert N, Hook R, Platt A, Smith C, Irvine F, Donaldson C, Jones E, Kelly J, Mander A, Murphy C, Pennington M, Pullen A, Redley M, Rowe S, Wason J. Ring H, et al. Among authors: murphy c. Trials. 2016 Jun 24;17(1):297. doi: 10.1186/s13063-016-1429-7. Trials. 2016. PMID: 27342377 Free PMC article. Clinical Trial.
Training nurses in a competency framework to support adults with epilepsy and intellectual disability: the EpAID cluster RCT.
Ring H, Howlett J, Pennington M, Smith C, Redley M, Murphy C, Hook R, Platt A, Gilbert N, Jones E, Kelly J, Pullen A, Mander A, Donaldson C, Rowe S, Wason J, Irvine F. Ring H, et al. Among authors: murphy c. Health Technol Assess. 2018 Feb;22(10):1-104. doi: 10.3310/hta22100. Health Technol Assess. 2018. PMID: 29457585 Free PMC article. Clinical Trial.
Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study.
Pennington B, Alshreef A, Flight L, Metry A, Poku E, Hykin P, Sivaprasad S, Prevost AT, Vasconcelos JC, Murphy C, Kelly J, Yang Y, Lotery A, Williams M, Brazier J. Pennington B, et al. Among authors: murphy c. Pharmacoeconomics. 2021 Aug;39(8):913-927. doi: 10.1007/s40273-021-01026-5. Epub 2021 Apr 26. Pharmacoeconomics. 2021. PMID: 33900585 Free PMC article. Clinical Trial.
Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT.
Hykin P, Prevost AT, Sivaprasad S, Vasconcelos JC, Murphy C, Kelly J, Ramu J, Alshreef A, Flight L, Pennington R, Hounsome B, Lever E, Metry A, Poku E, Yang Y, Harding SP, Lotery A, Chakravarthy U, Brazier J. Hykin P, et al. Among authors: murphy c. Health Technol Assess. 2021 Jun;25(38):1-196. doi: 10.3310/hta25380. Health Technol Assess. 2021. PMID: 34132192 Free PMC article. Clinical Trial.
Correction to: Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study.
Pennington B, Alshreef A, Flight L, Metry A, Poku E, Hykin P, Sivaprasad S, Prevost AT, Vasconcelos JC, Murphy C, Kelly J, Yang Y, Lotery A, Williams M, Brazier J. Pennington B, et al. Among authors: murphy c. Pharmacoeconomics. 2021 Sep;39(9):1099. doi: 10.1007/s40273-021-01057-y. Pharmacoeconomics. 2021. PMID: 34148190 Free PMC article. No abstract available.
Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosis.
Jones AR, Jivraj N, Balendra R, Murphy C, Kelly J, Thornhill M, Young C, Shaw PJ, Leigh PN, Turner MR, Steen IN, McCrone P, Al-Chalabi A. Jones AR, et al. Among authors: murphy c. Amyotroph Lateral Scler Frontotemporal Degener. 2014 Jun;15(3-4):285-91. doi: 10.3109/21678421.2013.872149. Epub 2014 Feb 7. Amyotroph Lateral Scler Frontotemporal Degener. 2014. PMID: 24641613
A multicentre randomiSed controlled TRial of IntraVEnous immunoglobulin compared with standard therapy for the treatment of transverse myelitis in adults and children (STRIVE).
Absoud M, Brex P, Ciccarelli O, Diribe O, Giovannoni G, Hellier J, Howe R, Holland R, Kelly J, McCrone P, Murphy C, Palace J, Pickles A, Pike M, Robertson N, Jacob A, Lim M. Absoud M, et al. Among authors: murphy c. Health Technol Assess. 2017 May;21(31):1-50. doi: 10.3310/hta21310. Health Technol Assess. 2017. PMID: 28639937 Free PMC article. Clinical Trial.
4,791 results